^
    7ms
    IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma (clinicaltrials.gov)
    P1, N=9, Not yet recruiting, Beijing Immunochina Medical Science & Technology Co., Ltd.
    New P1 trial • CAR T-Cell Therapy
    |
    cyclophosphamide • IM83
    3years
    Safety and Efficacy Evaluation of IM83 CAR-T Cells for Patients With Advanced Liver Tumors (clinicaltrials.gov)
    P1, N=12, Recruiting, Beijing Immunochina Medical Science & Technology Co., Ltd.
    Clinical • New P1 trial • CAR T-Cell Therapy
    |
    PD-L1 (Programmed death ligand 1) • PD-1 (Programmed cell death 1) • GPC3 (Glypican 3)
    |
    GPC3 expression
    |
    IM83
    over3years
    Clinical Study of Intratumoral Injection of CAR-T Cells in the Treatment of Advanced Liver Tumors (clinicaltrials.gov)
    P1, N=10, Recruiting, Beijing Immunochina Medical Science & Technology Co., Ltd.
    Clinical • New P1 trial • CAR T-Cell Therapy
    |
    GPC3 (Glypican 3)
    |
    GPC3 expression
    |
    IM83